We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDST
4101
DELISTED
Goldenstone Acquisition Limited Common Stock
GDST
$10K ﹤0.01%
982
-17
-2% -$171
CTV
4102
DELISTED
Innovid Corp.
CTV
$10K ﹤0.01%
6,084
-1,133
-16% -$3.07K
LUMO
4103
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$10K ﹤0.01%
2,797
+215
+8% +$1.41K
VTNR
4104
DELISTED
Vertex Energy, Inc
VTNR
$10K ﹤0.01%
1,585
-28,255
-95% -$211K
EGRX
4105
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$10K ﹤0.01%
357
-7,600
-96% -$242K
VWE
4106
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
$10K ﹤0.01%
3,050
-3,496
-53% -$10.7K
EFTR
4107
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$10K ﹤0.01%
909
+253
+39% +$3.21K
DLA
4108
DELISTED
Delta Apparel Inc.
DLA
$10K ﹤0.01%
914
+202
+28% +$2.75K
TGAN
4109
DELISTED
Transphorm, Inc. Common Stock
TGAN
$10K ﹤0.01%
1,767
-998
-36% -$5.87K
SCX
4110
DELISTED
The L.S. Starrett Company
SCX
$10K ﹤0.01%
1,404
+307
+28% +$2.46K
NURO
4111
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$10K ﹤0.01%
848
+821
+3,041% +$11.7K
SMMF
4112
DELISTED
Summit Financial Group, Inc.
SMMF
$10K ﹤0.01%
426
-1,247
-75% -$34.4K
VINO
4113
DELISTED
Gaucho Group Holdings, Inc. Common Stock
VINO
$10K ﹤0.01%
87
+76
+691% +$14.5K
PETV
4114
DELISTED
PetVivo Holdings, Inc. Common Stock
PETV
$10K ﹤0.01%
5,046
+819
+19% +$1.91K
SCTL
4115
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$10K ﹤0.01%
6,575
-2,458
-27% -$3.86K
JOAN
4116
DELISTED
JOANN, Inc. Common Stock
JOAN
$10K ﹤0.01%
3,639
+2,061
+131% +$9.74K
SOVO
4117
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
$10K ﹤0.01%
689
-4,878
-88% -$68.3K
GOL
4118
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$10K ﹤0.01%
3,785
-2,946
-44% -$9.6K
OTEC
4119
DELISTED
OceanTech Acquisitions I Corp. Class A Common Stock
OTEC
$10K ﹤0.01%
983
-17
-2% -$175
SLGC
4120
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$10K ﹤0.01%
3,867
-16,455
-81% -$45.9K
LVOX
4121
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$10K ﹤0.01%
3,462
-1,109
-24% -$2.92K
FTCH
4122
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$10K ﹤0.01%
2,074
-12,106
-85% -$84.3K
CCVI.U
4123
DELISTED
Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
CCVI.U
$10K ﹤0.01%
997
APRN
4124
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$10K ﹤0.01%
1,054
+612
+138% +$11.5K
AVID
4125
DELISTED
Avid Technology Inc
AVID
$10K ﹤0.01%
400
-1,058
-73% -$27.9K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.